» Articles » PMID: 19712440

Upregulation of MiRNA Hsa-miR-342-3p in Experimental and Idiopathic Prion Disease

Overview
Publisher Biomed Central
Date 2009 Aug 29
PMID 19712440
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of our study was to analyze the differential expression of miRNAs in the brains of BSE-infected cynomolgus macaques as a model for Creutzfeldt-Jakob disease (CJD). MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression by mRNA targeting. Among other functions they contribute to neuronal development and survival. Recently, the lack of miRNA processing has been shown to promote neurodegeneration and deregulation of several miRNAs has been reported to be associated with Scrapie in mice. Therefore, we hypothesized that miRNAs are also regulated in response to human prion disease. We have applied miRNA-microarrays to identify deregulated miRNA candidates in brains of BSE-infected macaques. Shock-frozen brain sections of six BSE-infected and five non-infected macaques were used to validate regulated miRNA candidates by two independent qRT-PCR-based methods. Our study revealed significant upregulation of hsa-miR-342-3p and hsa-miR-494 in the brains of BSE-infected macaques compared to non-infected animals. In a pilot study we could show that hsa-miR-342-3p was also upregulated in brain samples of human type 1 and type 2 sporadic CJD. With respect to the reported regulation of this miRNA in Scrapie-infected mice, we propose that upregulation of hsa-miR-342-3p may be a general phenomenon in late stage prion disease and might be used as a novel marker for animal and human TSEs.

Citing Articles

Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases.

Wiersema A, Rennenberg A, Smith G, Varderidou-Minasian S, Pasterkamp R Cell Mol Life Sci. 2024; 81(1):479.

PMID: 39627617 PMC: 11615177. DOI: 10.1007/s00018-024-05522-7.


Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives.

Afonso G, Cavaleiro C, Valero J, Mota S, Ferreiro E Cells. 2023; 12(13).

PMID: 37443797 PMC: 10340215. DOI: 10.3390/cells12131763.


Single-Molecule Sensor for High-Confidence Detection of miRNA.

Wijesinghe K, Kanak M, Harrell J, Dhakal S ACS Sens. 2022; 7(4):1086-1094.

PMID: 35312280 PMC: 9112324. DOI: 10.1021/acssensors.1c02748.


Gene expression and epigenetic markers of prion diseases.

Vire E, Mead S Cell Tissue Res. 2022; 392(1):285-294.

PMID: 35307791 PMC: 10113299. DOI: 10.1007/s00441-022-03603-2.


Influence of age and sex on microRNA response and recovery in the hippocampus following sepsis.

Rani A, Barter J, Kumar A, Stortz J, Hollen M, Nacionales D Aging (Albany NY). 2022; 14(2):728-746.

PMID: 35094981 PMC: 8833110. DOI: 10.18632/aging.203868.


References
1.
Bilen J, Liu N, Burnett B, Pittman R, Bonini N . MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell. 2006; 24(1):157-63. DOI: 10.1016/j.molcel.2006.07.030. View

2.
Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R . An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA. 2005; 11(9):1461-70. PMC: 1370829. DOI: 10.1261/rna.2610405. View

3.
Packer A, Xing Y, Harper S, Jones L, Davidson B . The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci. 2009; 28(53):14341-6. PMC: 3124002. DOI: 10.1523/JNEUROSCI.2390-08.2008. View

4.
Wang W, Rajeev B, Stromberg A, Ren N, Tang G, Huang Q . The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008; 28(5):1213-23. PMC: 2837363. DOI: 10.1523/JNEUROSCI.5065-07.2008. View

5.
Schaefer A, OCarroll D, Tan C, Hillman D, Sugimori M, Llinas R . Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med. 2007; 204(7):1553-8. PMC: 2118654. DOI: 10.1084/jem.20070823. View